Skip to main content
. 2021 Mar 9;3(7):896–903. doi: 10.1016/j.cjco.2021.02.015

Table 1.

Patient characteristics

Characteristic Total (n = 39) Medical cohort (n = 23) Surgical cohort (n = 16) P
Age, y 38.6 ± 11 38.4 ± 12 39.2 ± 12 0.8
Female 21 (52) 12 (52) 9 (56) 0.8
Diabetes 2 (5) 1 (4) 1 (6) 1.0
Hypertension 4 (10) 2 (9) 2 (12) 1.0
Dyslipidemia 2 (5) 1 (4) 1 (6) 1.0
Smoking 10 (26) 3 (13) 7 (44) 0.06
Alcohol abuse 3 (8) 1 (4) 2 (12) 0.5
Previous IE 12 (31) 6 (26) 6 (37) 1.0
Heart failure 5 (13) 2 (9) 3 (19) 0.6
Stroke/TIA 5 (13) 1 (4) 4 (25) 0.1
Pacemaker 1 (2) 0 1 (6) 1.0
Renal insufficiency 4 (10) 2 (9) 2 (12) 1.0
COPD 3 (8) 3 (13) 0 0.2
Chronic liver disease 2 (5) 1 (4) 1 (6) 1.0
Fungal infection 3 (8) 2 (9) 1 (6) 1.0
Infectious history
 Hepatitis B 4 (10) 4 (17) 0 0.1
 Hepatitis C 26 (67) 16 (70) 10 (62) 0.6
 HIV 4 (10) 2 (9) 2 (12) 1.0

Values are n (%) or mean ± standard deviation, unless otherwise indicated.

CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVA, cardiovascular accident; DM, diabetes mellitus; DVT, deep vein thrombosis; HIV, human immunodeficiency virus; HT, hypertension; IE, infective endocarditis; TIA, transit ischemic attack.